Lista de obras - Raffaele Giusti - Dominio Público Uruguay

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

artículo científico publicado en 2019

A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab

artículo científico publicado en 2019

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-r

scientific article published on 04 February 2020

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation

scientific article published on 01 October 2020

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

artículo científico publicado en 2020

Cancer Care After Natural Disaster: Different Countries, Similar Problems

scientific article published on 01 July 2019

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective

artículo científico publicado en 2020

Caring for Cancer Patients After the Italian Earthquakes: A Proposal From the Field.

artículo científico publicado en 2017

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

artículo científico publicado en 2017

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

artículo científico publicado en 2020

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

scientific article published on 22 February 2019

Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors

scientific article published on 08 June 2019

Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis.

artículo científico publicado en 2015

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50

artículo científico publicado en 2020

Comment on 'What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion'.

artículo científico publicado en 2016

Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report

artículo científico publicado en 2017

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

scientific article published on 21 February 2019

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

artículo científico publicado en 2019

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

artículo científico publicado en 2020

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

artículo científico publicado en 2020

Four lines of anaplastic lymphoma kinase inhibitors and brain radiotherapy in a long-surviving non-small-cell lung cancer anaplastic lymphoma kinase-positive patient with leptomeningeal carcinomatosis

scientific article published on 01 February 2019

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)

article

Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment

scientific article published on 03 February 2020

Immigrants Accessing End-of-Life Care in Italy: The Tuscany Tumor Association Experience

artículo científico publicado en 2016

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

artículo científico publicado en 2020

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

artículo científico publicado en 2020

Integration between oncology and palliative care: a plan for the next decade?

scientific article published on 12 May 2017

Is it possible to teach pain therapy playing basketball?

artículo científico publicado en 2016

Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law.

artículo científico publicado en 2017

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

artículo científico publicado en 2020

Multidisciplinary approach to fetal adenocarcinoma of the lung: A case report

artículo científico publicado en 2014

Nutrition in patients with cancer: a new area for medical oncologists? A practising oncologist's interdisciplinary position paper.

artículo científico publicado en 2018

Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes

artículo científico publicado en 2017

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study ⬇️

artículo científico

Prevention and management of osteonecrosis of the jaw secondary to bone-targeted therapy in patients with kidney cancer.

artículo científico publicado en 2016

Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.

artículo científico publicado en 2019

Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma

artículo científico publicado en 2016

Rapid resolution of refractory chemotherapy-induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report

artículo científico publicado en 2014

Re. "Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey"

artículo científico publicado en 2016

Resolution of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) during Nivolumab therapy for non-small cell lung cancer: a case report

scientific article published on 06 January 2018

The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy

artículo científico publicado en 2020

The Incidence of Alcoholism in Patients with Advanced Cancer Receiving Active Treatment in Two Tertiary Care Centers in Italy

artículo científico publicado en 2019

The point of pain in head and neck cancer

scientific article published on 05 April 2019

The use of fentanyl in pain management in head and neck cancer patients: a narrative review

scientific article published on 10 October 2017

Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1

artículo científico publicado en 2020

Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature

artículo científico publicado en 2016

Unexpected serious aplastic anemia from PD-1 inhibitors: beyond what we know

scientific article published on 21 June 2019

What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes

scientific article published on 01 May 2019

[Health as a human right, the right to life and the freedom to choose.]

scientific article published on 01 May 2020

[Immunotherapy in non-small cell lung cancer patients: back to the future.]

scientific article published on 01 December 2019

[Symptom assessment and chemical coping detection: the assessment of the cancer patient's symptoms between consumption, use and abuse.]

artículo científico publicado en 2019

[The management of cancer patients during natural disasters: the oncologist's resilience and the role of scientific societies.]

artículo científico publicado en 2018

Lista de obras de Raffaele Giusti

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-r

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Cancer Care After Natural Disaster: Different Countries, Similar Problems

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective

Caring for Cancer Patients After the Italian Earthquakes: A Proposal From the Field.

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors

Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis.

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50

Comment on 'What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion'.

Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

Four lines of anaplastic lymphoma kinase inhibitors and brain radiotherapy in a long-surviving non-small-cell lung cancer anaplastic lymphoma kinase-positive patient with leptomeningeal carcinomatosis

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)

Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment

Immigrants Accessing End-of-Life Care in Italy: The Tuscany Tumor Association Experience

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Integration between oncology and palliative care: a plan for the next decade?

Is it possible to teach pain therapy playing basketball?

Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law.

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

Multidisciplinary approach to fetal adenocarcinoma of the lung: A case report

Nutrition in patients with cancer: a new area for medical oncologists? A practising oncologist's interdisciplinary position paper.

Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study ⬇️

Prevention and management of osteonecrosis of the jaw secondary to bone-targeted therapy in patients with kidney cancer.

Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.

Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma

Rapid resolution of refractory chemotherapy-induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report

Re. "Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey"

Resolution of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) during Nivolumab therapy for non-small cell lung cancer: a case report

The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy

The Incidence of Alcoholism in Patients with Advanced Cancer Receiving Active Treatment in Two Tertiary Care Centers in Italy

The point of pain in head and neck cancer

The use of fentanyl in pain management in head and neck cancer patients: a narrative review

Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1

Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature

Unexpected serious aplastic anemia from PD-1 inhibitors: beyond what we know

What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes

[Health as a human right, the right to life and the freedom to choose.]

[Immunotherapy in non-small cell lung cancer patients: back to the future.]

[Symptom assessment and chemical coping detection: the assessment of the cancer patient's symptoms between consumption, use and abuse.]

[The management of cancer patients during natural disasters: the oncologist's resilience and the role of scientific societies.]